Infectious Diseases
The Infectious Diseases team at Burjeel Cancer Institute specializes in preventing, diagnosing, and managing infections in cancer patients. Our multidisciplinary team of infectious disease specialists works closely with oncologists to ensure comprehensive care, addressing the unique immune challenges faced by cancer patients. We utilize advanced diagnostic tools and infection prevention strategies to minimize complications and enhance treatment outcomes, prioritizing patient safety and well-being throughout their cancer journey.
Conditions We Treat
- Infections in Immunocompromised Patients
- Human Papillomavirus (HPV) and cervical cancer
- Hepatitis B and C and liver cancer
- Epstein-Barr Virus (EBV) and lymphoma
- Febrile Neutropenia
- Healthcare-Associated Infections
- Post-Surgical Infections
Treatment Options
Targeted Antimicrobial Therapy
Prophylactic Treatments
Vaccination Programs
Immunoglobulin Therapy
Antimicrobial Stewardship
Our Approach to Treatment
Integrated Cancer-Infection Management
Individualized Risk Assessments
Rapid Intervention
Focus on Patient Education
Diagnostic and Monitoring Tools
Molecular Diagnostics
Biomarkers for Infection
Imaging Techniques
Drug Susceptibility Testing
Routine Surveillance
Supportive Care and Patient Services
Infection Prevention Programs
Home-Based Care
Psychological Support
Oncology-Specific Clinics
Support Groups
Advanced Treatment Techniques
Immunotherapy-Related Infections
Targeted Biologic Therapies
Fecal Microbiota Transplantation (FMT)
Precision Medicine in Infection
Antiviral Prophylaxis for Oncogenic Viruses
Patient Journey
Pre-Treatment Preparation
Risk assessment for potential infections & vaccination and prophylactic strategies
During Treatment
Regular monitoring for febrile neutropenia and opportunistic infections with Immediate response to suspected infections
Post-Treatment Recovery
Management of long-term infection risks & Addressing lingering immune dysfunction
Long-Term Surveillance
Monitoring for recurrence of infections or secondary cancers
